Lysis and neutralization method for production of pharmaceutical grade plasmid DNA
The present invention is a short duration lysis and neutralization process developed for the production of pharmaceutical grade plasmid DNA. This process includes the mixing of concentrated bacterial suspension and lysis solution through a “T” or “Y” shaped device, followed by the addition of neutralization solution through a another “T” or “Y” shaped device. A thorough mixing of bacterial suspension, lysis solution, and neutralization solution was achieved by addition of static mixer(s) at post-lysis and post-neutralization steps. The neutralized bacterial suspension was clarified by bag-filtration to remove macromolecules and host cell chromosomal DNA-protein precipitates.
1 . A process for purifying plasmid DNA from prokaryotic cells, comprising:
(a) digesting the cells;
(b) incubating the cells in the presence of alkali and a detergent for about 30 seconds to 2 minutes to effect lysis and solubilization thereof;
(c) removing lysate contaminants from the cells to provide a plasmid DNA solution;
(d) filtering the solution through a tangential flow filtration device to obtain a retentate containing the plasmid DNA; and
(e) collecting the retentate, whereby enzymes are not used in any of the above steps to digest RNA.
2 . The process of claim 1 , wherein the cells are bacterial cells.
3 . The process of claim 1 , wherein the cells are E. coli cells.
4 . The process of claim 1 , wherein the plasmid DNA has a size ranging from about 2 to 15 kilobases.
5 . The process of claim 1 , wherein step (b) is carried out for about 30 seconds to 1 minute.
6 . The process of claim 1 , wherein the process is a continuous process.
7 . The process of claim 1 , wherein the process is a batch process.
8 . The process of claim 1 , wherein the filtration device has a membrane with a nominal molecular weight cutoff of greater than about 100 k NMWC.
10 . The process of claim 1 , further comprising recovering the plasmid DNA from the retentate.
11 . The process of claim 1 , further comprising subjecting the retentate to reverse-phase chromatography.
12 . The process of claim 1 , wherein the detergent is ionic.
13 . The process of claim 1 , wherein the detergent is anionic.
14 . The process of claim 14 , wherein the detergent is sodium dodecyl sulfate, cholic acid, or deoxycholic acid.
15 . The process of claim 1 , wherein the plasmid DNA has a molecular weight over 7000 kDa.